A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndrome
Critical Care Sep 13, 2019
He H, Sun B, Liang L, et al. - In this prospective, multicenter, randomized controlled trial, researchers investigated the ability of early noninvasive ventilation (NIV) for attenuating the requirement for invasive ventilation in patients with pneumonia-induced early mild acute respiratory distress syndrome (ARDS). They compared NIV with conventional administration of oxygen through a Venturi mask. The numbers of patients who satisfied the intubation criteria were assessed as the primary outcome. In multivariate analysis, minute ventilation greater than 11 L/min at 48 h was shown to independently confer risk for NIV failure. Among patients with pneumonia-induced early mild ARDS, no decrease in the requirement for intubation was brought about by treatment with NIV, however, NIV vs standard oxygen therapy resulted in improved PaO2/FIO2 (arterial oxygen tension/inspired oxygen fraction). NIV failure may be predicted by high minute ventilation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries